Alto Neuroscience Reports Q3 2026 Quarterly Results

What Happened
Alto Neuroscience, Inc. announced and filed an 8-K on August 12, 2026 reporting its financial results for the fiscal quarter ended June 30, 2026 (Item 2.02: Results of Operations and Financial Condition). The company furnished a press release as Exhibit 99.1 to the filing, which is incorporated by reference. The report was signed by Amit Etkin, M.D., Ph.D., President and Chief Executive Officer.

Key Details

• Filing date: August 12, 2026; reporting period: quarter ended June 30, 2026.
• Item reported: 2.02 (Results of Operations and Financial Condition); press release furnished as Exhibit 99.1.
• The 8-K includes an Inline XBRL cover page file (Exhibit 104).
• Signed and certified by CEO Amit Etkin.

Why It Matters
This 8-K notifies investors that Alto has released its quarterly earnings/financial results; the press release (Exhibit 99.1) will contain the specific revenue, expense, cash position, and other quarterly metrics investors typically track. Retail investors should review the linked press release and the company's Form 10-Q (if filed) for the full financial figures and context. No other corporate actions (e.g., executive departures, mergers, or bankruptcy notices) were reported in this filing.